Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Personality Characteristics and Compliance With Antiglaucoma Medication (GDC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Yonsei University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Yonsei University
ClinicalTrials.gov Identifier:
NCT00481494
First received: May 31, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

Personality traits may influence to the drug compliance in glaucoma patients.


Condition
Glaucoma

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Personality Characteristics and Compliance With Antiglaucoma Medication

Resource links provided by NLM:


Further study details as provided by Yonsei University:

Estimated Enrollment: 150
Study Start Date: May 2007
Estimated Study Completion Date: October 2007
Detailed Description:

In chronic diseases, especially asymptomatic at early stage, drug compliance has been reported as an important factor to control them. And personality traits are associated with the drug compliance. However, there was few study to consider this relationship. We want to find the association the personality characteristics and drug compliance in glaucoma patients.

  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic glaucoma
  • Topical anti-glaucoma medications

Exclusion Criteria:

  • Oral glaucoma medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00481494

Contacts
Contact: Chan Yun Kim, MD, PhD 82-2-2228-3580 kcyeye@yumc.yonsei.ac.kr

Locations
Korea, Republic of
Severance Hospital, Yonsei University College of Medicine Recruiting
Seoul, Korea, Republic of, 120-752
Contact: Chan Yun Kim, MD, PhD    82-2-2228-3580    kcyeye@yumc.yonsei.ac.kr   
Sponsors and Collaborators
Yonsei University
Investigators
Study Chair: Chan Yun Kim, MD, PhD Department of Ophthalmology, Yonsei University College of Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00481494     History of Changes
Other Study ID Numbers: 4-2007-0092
Study First Received: May 31, 2007
Last Updated: May 31, 2007
Health Authority: Republic of Korea: Institutional Review Board

Keywords provided by Yonsei University:
Glaucoma
Drug compliance
Personality

Additional relevant MeSH terms:
Glaucoma
Eye Diseases
Ocular Hypertension

ClinicalTrials.gov processed this record on November 25, 2014